|
Q1 FY2020
As of Jun 30, 2019
|
Q4 FY2019
As of Mar 31, 2019
|
Q3 FY2019
As of Dec 31, 2018
|
Q2 FY2019
As of Sep 30, 2018
|
Q1 FY2019
As of Jun 30, 2018
|
Q4 FY2018
As of Mar 31, 2018
|
Q3 FY2018
As of Dec 31, 2017
|
Q2 FY2018
As of Sep 30, 2017
|
Q1 FY2018
As of Jun 30, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash and cash equivalents | |||||||||
| Cash | |||||||||
| Prepaid expenses and other current assets | |||||||||
| Total Current Assets | |||||||||
| Investment securities held in Trust Account | |||||||||
| Total Assets | |||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Income taxes payable | |||||||||
| Working capital loan | |||||||||
| Promissory note – related party | |||||||||
| Total Current Liabilities | |||||||||
| Deferred underwriting fee payable | |||||||||
| Deferred underwriting fees | |||||||||
| Deferred legal fees payable | |||||||||
| Total Liabilities | |||||||||
| Common stock subject to possible redemption, $0.0001 par value; 4,433 and 13,522,841 shares at redemption value of approximately $10.23 as of June 30, 2019 and 10.13 as of March 31, 2019, respectively | |||||||||
| Stockholders' Equity | |||||||||
| Common stock, $0.0001 par value; 100,000,000 shares authorized; 6,577,232 and 6,409,478 shares issued and outstanding (excluding 4,433 and 13,522,841 shares subject to possible redemption) as of June 30, 2019 and March 31, 2019, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Retained earnings | |||||||||
| Total Stockholders' Equity | |||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...
